Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
10.96
-0.65 (-5.60%)
Mar 5, 2026, 4:00 PM EST - Market closed
Armata Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Armata Pharmaceuticals stock have an average target of 15, which predicts an increase of 36.86% from the current stock price of 10.96.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Armata Pharmaceuticals stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $15 | Strong Buy | Maintains | $9 → $15 | +36.86% | Feb 23, 2026 |
| Jones Trading | Jones Trading | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +36.86% | Jan 5, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $9 | Strong Buy | Maintains | $7 → $9 | -17.88% | May 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | -36.13% | Dec 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | -36.13% | Nov 14, 2024 |
Financial Forecast
Revenue This Year
4.64M
from 5.17M
Decreased by -10.30%
Revenue Next Year
n/a
from 4.64M
EPS This Year
-1.67
from -0.89
EPS Next Year
-1.11
from -1.67
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.6M | n/a | |||
| Avg | 4.6M | n/a | |||
| Low | 3.7M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 7.6% | - | |||
| Avg | -10.3% | - | |||
| Low | -28.0% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.62 | -1.14 | |
| Avg | -1.67 | -1.11 | |
| Low | -1.70 | -1.07 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.